草本免疫增強劑市場：未來預測（至2034年）－按產品類型、劑型、成分、應用、最終用戶和地區分類的全球分析

根據 Stratistics MRC 預測，全球草藥免疫增強劑市場預計將在 2026 年達到 246 億美元，並在預測期內以 8.8% 的複合年成長率成長，到 2034 年達到 484 億美元。

草本免疫增強劑（免疫強化劑）是指植物來源的保健產品，包括草藥補充劑、維生素和礦物質組合藥物、益生菌製劑、機能性食品和飲料以及精油產品。這些產品採用傳統且經過科學驗證的草藥成分體系，例如紫錐花、接骨木果、南非睡茄、薑黃、人參和藥用真菌提取物，透過天然生物活性化合物的作用，支持免疫系統功能，增強自然防禦機制，並提高對感染疾病的抵抗力。

消費者對預防醫學自我護理的投資

消費者積極採用草藥和天然免疫支持產品進行預防性健康自我護理，將其視為積極的健康投資，這一趨勢正在加速發展，並成為成長要素。這是因為各階層的消費者都越來越傾向於尋求易於取得的天然替代方案，以取代被動的藥物介入來維持免疫健康。由於醫療保健系統的費用高昂以及人們對天然療法的興趣日益濃厚，草藥免疫增強劑的使用範圍正在從熱衷於天然健康理念的消費者擴展到普通藥劑師和超市消費者，他們都希望透過易於獲取的植物性產品來輕鬆增強免疫力。

臨床證據和監管審查

監管機構和媒體對草藥免疫產品健康聲明的審查日益嚴格，加上許多植物成分缺乏商業性適用劑量下的臨床證據，這給草藥免疫增強劑生產商帶來了品牌信譽風險和合規成本。美國聯邦貿易委員會（FTC）針對未經證實的COVID-19免疫聲明發出警告，並持續打擊結構性和功能性聲明，這些舉措限制了針對草藥免疫產品的消費者宣傳活動的有效性。這些草藥免疫產品雖然有傳統用途支持，但缺乏隨機調查方法臨床試驗的充分證據。

阿育吠陀與傳統醫學的融合

西方消費者對阿育吠陀、中醫和其他傳統植物醫學體系的接受度日益提高，這為融合了正宗傳統防腐知識和現代品質標準的草藥免疫療法產品創造了機遇，使其得以在高階市場佔據一席之地。達布爾（Dabul）、喜馬拉雅（Himalaya）和帕坦伽利（Patanjali）等品牌進軍西方市場，以及西方高階品牌對傳統處方認可度的提升，共同構成了一個融合的商業性機遇，能夠滿足消費者對具有文化合法性的傳統草藥免疫療法的需求。

免疫調節劑領域的製藥競爭

隨著實證免疫調節藥物和干涉措施（例如單株抗體和針對常見免疫力缺乏的標靶免疫療法）的研發管線不斷擴展，一種新的臨床理論正在形成：對於有特定免疫健康問題的消費者而言，藥物干預優於植物來源替代療法。這可能會限制草藥免疫增強劑市場在那些注重臨床證據品質而非天然產品定位的健康意識消費者中的滲透率。

新冠疫情的影響：

新冠疫情引發了現代商業史上對草本免疫增強劑需求最大規模的激增。全球消費者同時尋求免疫支持產品，導致接骨木莓、紫錐花、鋅和維生素D產品嚴重供不應求。疫情後時代，人們對免疫健康的持續關注度甚至超過了疫情前水平，永久擴大了草本免疫增強劑的消費群體。此外，免疫支持補充劑的日常服用也已在以前從未接觸過此類產品的人群中普及開來。

在預測期內，精油細分市場預計將成為最大的細分市場。

在預測期內，精油細分市場預計將佔據最大的市場佔有率。這是因為用於增強免疫力的精油混合物，例如尤加利、牛至、茶樹和百里香，已被廣泛商業性治療和芳香療法，並在草本免疫類產品中創造了最大的總合總額。高價優質精油混合物以及擴香器設備生態系統中的補充裝銷售，共同構成了穩定且高頻的收入來源，從而鞏固了該細分市場的領先地位。

在預測期內，平板電腦細分市場預計將呈現最高的複合年成長率。

在預測期內，片劑市場預計將呈現最高的成長率。這是因為草藥免疫增強劑的片劑配方正推動其透過藥房管道的分銷量不斷成長。這些產品透過熟悉的藥品式給藥方式，以及降低消費者接受天然產品的門檻，觸及了以往服務不足的消費族群。此外，植物性片劑配方技術的進步提高了活性成分含量和生物利用度，從而增強了高階草藥免疫片劑產品在競爭激烈的市場環境中的功效優勢。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率。這主要是因為美國擁有全球最大的營養補充品市場，其草藥免疫產品零售體系已相當完善，涵蓋亞馬遜、沃爾瑪以及其他專業的天然保健品通路。此外，Nature's Bounty、NOW Foods 和葛蘭素史克 (GSK) 的天然補充劑系列等知名品牌在國內市場銷售額顯著，而且隨著疫情意識的提高，消費者也表現出強烈的意願購買增強免疫力的補充劑。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率。這是因為印度和中國擁有根深蒂固的傳統草藥文化，為現代草藥免疫補充劑的接受度提供了天然基礎；中產階級消費群體正在迅速壯大，並加大對高階保健品的投入；此外，達布爾（Dabul）、喜馬拉雅（Himalaya）和帕坦伽利（Patanjali）等本土草藥企業的發展，正在為亞洲消費市場的真正經濟價格打造極實惠的貨幣、經濟

免費客製化服務：

訂閱本報告的用戶可享有以下免費自訂選項之一：

• 公司簡介
  • 對其他公司（最多 3 家公司）進行全面分析
  • 對主要公司進行SWOT分析（最多3家公司）
• 區域分類
  • 根據客戶興趣量身定做的主要國家/地區的市場估算、預測和複合年成長率（註：基於可行性檢查）
• 競爭性標竿分析
  • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

• 市場概覽及主要亮點
• 成長要素、挑戰與機遇
• 競爭格局概述
• 戰略考慮和建議

第2章：分析框架

• 分析的目標和範圍
• 相關人員分析
• 分析的前提條件與限制
• 分析方法

第3章 市場動態與趨勢分析

• 市場定義與結構
• 主要市場促進因素
• 市場限制與挑戰
• 投資成長機會和重點領域
• 產業威脅與風險評估
• 科技與創新趨勢
• 新興市場和高成長市場
• 監管和政策環境
• 感染疾病的影響及恢復前景

第4章：競爭環境與策略評估

• 波特五力分析
  • 供應商議價能力
  • 買方的議價能力
  • 替代產品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭
• 主要公司市佔率分析
• 產品基準評效和效能比較

第5章：全球草藥免疫增強劑市場：依產品類型分類

• 草藥補充劑
  • 紫錐花
  • 接骨木
  • 黃耆（Astragalus sinensis）
  • 參
  • 薑黃/薑黃素
• 維生素和礦物質
  • 維生素C
  • 維生素D
  • 鋅
• 益生菌
• 機能性食品和飲料
  • 增強免疫力的飲料
  • 營養強化零食
  • 功能茶
• 精油

第6章：全球草藥免疫增強劑市場：以劑型分類

• 藥片
• 膠囊
• 粉末
• 液體
• 軟糖咀嚼片
• 其他形式

第7章：全球草本免疫增強劑市場：依成分分類

• 植物
• 動物
• 微生物

第8章：全球草藥免疫增強劑市場：按應用領域分類

• 免疫系統支持
• 緩解感冒和流感症狀
• 過敏管理
• 呼吸系統健康
• 消化系統健康

第9章：全球草藥免疫增強劑市場：以最終用戶分類

• 成人
• 孩子們
• 老年人

第10章：全球草藥免疫增強劑市場：按地區分類

• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
  • 比利時
  • 瑞典
  • 瑞士
  • 波蘭
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 印尼
  • 泰國
  • 馬來西亞
  • 新加坡
  • 越南
  • 其他亞太國家
• 南美洲
  • 巴西
  • 阿根廷
  • 哥倫比亞
  • 智利
  • 秘魯
  • 其他南美國家
• 世界其他地區（RoW）
  • 中東
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 埃及
    • 摩洛哥
    • 其他非洲國家

第11章 策略市場資訊

• 產業加值網路與供應鏈評估
• 空白區域和機會地圖
• 產品演進與市場生命週期分析
• 通路、經銷商和打入市場策略的評估

第12章 產業趨勢與策略舉措

• 企業合併（M&A）
• 夥伴關係、聯盟和合資企業
• 新產品發布和認證
• 擴大生產能力和投資
• 其他策略舉措

第13章：公司簡介

• Bayer AG
• Abbott Laboratories
• Herbalife Nutrition Ltd.
• Amway Corp
• Nature's Bounty Co.
• GSK plc
• Nestle SA
• Reckitt Benckiser Group plc
• Pfizer Inc.
• Sanofi SA
• Dabur India Ltd.
• Himalaya Wellness Company
• Patanjali Ayurved Ltd.
• Blackmores Limited
• Swisse Wellness Pty Ltd.
• NOW Foods
• DSM-Firmenich AG
• Kerry Group plc

According to Stratistics MRC, the Global Herbal Immunity Boosters Market is accounted for $24.6 billion in 2026 and is expected to reach $48.4 billion by 2034 growing at a CAGR of 8.8% during the forecast period. Herbal immunity boosters refer to plant-derived wellness products including botanical herbal supplements, vitamin and mineral formulations, probiotic preparations, functional foods and beverages, and essential oil products delivered in tablet, capsule, powder, liquid, gummy, and other forms that leverage traditional and evidence-informed herbal medicine ingredient systems including echinacea, elderberry, ashwagandha, turmeric, ginseng, and medicinal mushroom extracts to support immune system function, enhance natural defense mechanisms, and build resilience against infectious illness through natural bioactive compound mechanisms.

Market Dynamics:

Driver:

Preventive Health Consumer Self-Care Investment

Accelerating mainstream consumer adoption of preventive health self-care approaches using herbal and natural immunity support products as proactive wellness investments represents the primary market growth driver as consumers across all demographic segments increasingly seek accessible natural alternatives to reactive pharmaceutical intervention for immune health maintenance. Healthcare system access cost barriers and growing natural medicine interest are expanding herbal immunity booster adoption from dedicated natural health consumers to mainstream pharmacy and grocery shoppers seeking convenient immune support through familiar botanical ingredient products.

Restraint:

Clinical Evidence Regulatory Scrutiny

Increasing regulatory and media scrutiny of herbal immunity product health claims requiring clinical evidence substantiation that many botanical ingredients lack at commercially relevant doses creates brand credibility risk and compliance cost burden for herbal immunity booster manufacturers. FTC warning letters targeting unsubstantiated COVID-19 immunity claims and continuing enforcement of structure-function claim limitations constrain consumer education effectiveness for herbal immunity products whose benefits are well-supported in traditional use but inadequately documented through randomized controlled clinical trial methodology standards.

Opportunity:

Ayurvedic and Traditional Medicine Integration

Growing mainstream Western consumer openness to Ayurvedic, Traditional Chinese Medicine, and other traditional botanical medicine systems creates premium market positioning opportunities for herbal immunity products incorporating authentic traditional formulation knowledge with modern quality standardization. Dabur, Himalaya, and Patanjali brand expansion into Western markets alongside premium Western brand adoption of traditional formulation credentials represent converging commercial opportunities to capture consumer demand for culturally validated traditional herbal immunity traditions.

Threat:

Pharmaceutical Immune Modulator Competition

Growing pharmaceutical pipeline of evidence-based immune modulation drugs and interventions including monoclonal antibodies and targeted immune therapy for common immune deficiency conditions creating clinical alternative narrative that positions pharmaceutical interventions as superior to botanical alternatives for consumers with specific immune health concerns, potentially limiting herbal immunity booster market penetration among health-literate consumers who prioritize clinical evidence quality over natural product positioning when making immune health investment decisions.

Covid-19 Impact:

COVID-19 created the most significant herbal immunity booster category demand surge in modern commercial history as consumers worldwide simultaneously sought immune support products generating acute supply shortages of elderberry, echinacea, zinc, and vitamin D products. Post-pandemic sustained immune health consciousness elevated above pre-pandemic baseline levels has permanently expanded the herbal immunity booster consumer population and normalized daily immune support supplementation across diverse demographic cohorts that previously did not engage with supplement categories.

The essential oils segment is expected to be the largest during the forecast period

The essential oils segment is expected to account for the largest market share during the forecast period, due to the broad commercial adoption of immunity-supporting essential oil formulations including eucalyptus, oregano, tea tree, and thyme in both therapeutic and aromatherapy application formats generating the highest combined retail value within the herbal immunity category. Premium essential oil blend products commanding substantial per-unit retail pricing combined with diffuser device ecosystem replenishment purchasing create consistent high-frequency revenue streams sustaining segment commercial leadership.

The tablets segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the tablets segment is predicted to witness the highest growth rate, driven by expanding mainstream pharmacy channel distribution of herbal immunity booster tablet formulations reaching previously underserved consumer demographics through familiar pharmaceutical-style dosing formats that reduce natural product adoption barriers, combined with advances in botanical tablet formulation enabling higher active compound loading and improved bioavailability that strengthen efficacy positioning for premium herbal immunity tablet products in competitive pharmacy retail environments.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to the United States hosting the world's largest dietary supplement market with established herbal immunity product retail infrastructure through Amazon, Walmart, and specialty natural health channels, leading brands including Nature's Bounty, NOW Foods, and GSK's natural supplement lines generating substantial domestic revenue, and high consumer willingness to invest in immune health supplementation following pandemic awareness.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to India and China hosting deeply embedded traditional herbal medicine cultures providing natural adoption foundations for modern herbal immunity supplement formats, rapidly growing middle-class consumer segments investing in premium wellness supplementation, and domestic herbal medicine industry development from Dabur, Himalaya, and Patanjali creating competitively priced regionally authentic herbal immunity product ranges for Asian consumer markets.

Key players in the market

Some of the key players in Herbal Immunity Boosters Market include Bayer AG, Abbott Laboratories, Herbalife Nutrition Ltd., Amway Corp, Nature's Bounty Co., GSK plc, Nestle S.A., Reckitt Benckiser Group plc, Pfizer Inc., Sanofi S.A., Dabur India Ltd., Himalaya Wellness Company, Patanjali Ayurved Ltd., Blackmores Limited, Swisse Wellness Pty Ltd., NOW Foods, DSM-Firmenich AG, and Kerry Group plc.

Key Developments:

In April 2026, Dabur India Ltd. launched an international range of Chyawanprash immunity supplement tablets reformulated for Western market palatability with retained authentic Ayurvedic formulation combining 40 botanical herbs and validated through independent clinical immunology research.

In March 2026, DSM-Firmenich AG introduced a new clinically validated herbal immunity ingredient complex combining standardized echinacea extract, elderberry anthocyanins, and zinc citrate demonstrating significant cold duration reduction in a 12-week randomized controlled trial.

In December 2025, Blackmores Limited expanded its herbal immunity range with a new practitioner-grade formulation featuring certified organic ashwagandha and reishi mushroom extract achieving TGA listing and ATMS practitioner recommendation program support across Australia.

Product Types Covered:

• Herbal Supplements
• Vitamins & Minerals
• Probiotics
• Functional Foods & Beverages
• Essential Oils

Forms Covered:

• Tablets
• Capsules
• Powder
• Liquid
• Gummies & Chewables
• Other Forms

Sources Covered:

• Plant
• Animal
• Microbial

Applications Covered:

• Immune System Support
• Cold & Flu Relief
• Allergy Management
• Respiratory Health
• Digestive Health

End Users Covered:

• Adults
• Children
• Geriatric

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Herbal Immunity Boosters Market, By Product Type

• 5.1 Herbal Supplements
  • 5.1.1 Echinacea
  • 5.1.2 Elderberry
  • 5.1.3 Astragalus
  • 5.1.4 Ginseng
  • 5.1.5 Turmeric/Curcumin
• 5.2 Vitamins & Minerals
  • 5.2.1 Vitamin C
  • 5.2.2 Vitamin D
  • 5.2.3 Zinc
• 5.3 Probiotics
• 5.4 Functional Foods & Beverages
  • 5.4.1 Immunity-Boosting Drinks
  • 5.4.2 Fortified Snacks
  • 5.4.3 Functional Teas
• 5.5 Essential Oils

6 Global Herbal Immunity Boosters Market, By Form

• 6.1 Tablets
• 6.2 Capsules
• 6.3 Powder
• 6.4 Liquid
• 6.5 Gummies & Chewables
• 6.6 Other Forms

7 Global Herbal Immunity Boosters Market, By Source

• 7.1 Plant
• 7.2 Animal
• 7.3 Microbial

8 Global Herbal Immunity Boosters Market, By Application

• 8.1 Immune System Support
• 8.2 Cold & Flu Relief
• 8.3 Allergy Management
• 8.4 Respiratory Health
• 8.5 Digestive Health

9 Global Herbal Immunity Boosters Market, By End User

• 9.1 Adults
• 9.2 Children
• 9.3 Geriatric

10 Global Herbal Immunity Boosters Market, By Geography

• 10.1 North America
  • 10.1.1 United States
  • 10.1.2 Canada
  • 10.1.3 Mexico
• 10.2 Europe
  • 10.2.1 United Kingdom
  • 10.2.2 Germany
  • 10.2.3 France
  • 10.2.4 Italy
  • 10.2.5 Spain
  • 10.2.6 Netherlands
  • 10.2.7 Belgium
  • 10.2.8 Sweden
  • 10.2.9 Switzerland
  • 10.2.10 Poland
  • 10.2.11 Rest of Europe
• 10.3 Asia Pacific
  • 10.3.1 China
  • 10.3.2 Japan
  • 10.3.3 India
  • 10.3.4 South Korea
  • 10.3.5 Australia
  • 10.3.6 Indonesia
  • 10.3.7 Thailand
  • 10.3.8 Malaysia
  • 10.3.9 Singapore
  • 10.3.10 Vietnam
  • 10.3.11 Rest of Asia Pacific
• 10.4 South America
  • 10.4.1 Brazil
  • 10.4.2 Argentina
  • 10.4.3 Colombia
  • 10.4.4 Chile
  • 10.4.5 Peru
  • 10.4.6 Rest of South America
• 10.5 Rest of the World (RoW)
  • 10.5.1 Middle East
    • 10.5.1.1 Saudi Arabia
    • 10.5.1.2 United Arab Emirates
    • 10.5.1.3 Qatar
    • 10.5.1.4 Israel
    • 10.5.1.5 Rest of Middle East
  • 10.5.2 Africa
    • 10.5.2.1 South Africa
    • 10.5.2.2 Egypt
    • 10.5.2.3 Morocco
    • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

• 11.1 Industry Value Network and Supply Chain Assessment
• 11.2 White-Space and Opportunity Mapping
• 11.3 Product Evolution and Market Life Cycle Analysis
• 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

• 12.1 Mergers and Acquisitions
• 12.2 Partnerships, Alliances, and Joint Ventures
• 12.3 New Product Launches and Certifications
• 12.4 Capacity Expansion and Investments
• 12.5 Other Strategic Initiatives

13 Company Profiles

• 13.1 Bayer AG
• 13.2 Abbott Laboratories
• 13.3 Herbalife Nutrition Ltd.
• 13.4 Amway Corp
• 13.5 Nature's Bounty Co.
• 13.6 GSK plc
• 13.7 Nestle S.A.
• 13.8 Reckitt Benckiser Group plc
• 13.9 Pfizer Inc.
• 13.10 Sanofi S.A.
• 13.11 Dabur India Ltd.
• 13.12 Himalaya Wellness Company
• 13.13 Patanjali Ayurved Ltd.
• 13.14 Blackmores Limited
• 13.15 Swisse Wellness Pty Ltd.
• 13.16 NOW Foods
• 13.17 DSM-Firmenich AG
• 13.18 Kerry Group plc

List of Tables

• Table 1 Global Herbal Immunity Boosters Market Outlook, By Region (2023-2034) ($MN)
• Table 2 Global Herbal Immunity Boosters Market Outlook, By Product Type (2023-2034) ($MN)
• Table 3 Global Herbal Immunity Boosters Market Outlook, By Herbal Supplements (2023-2034) ($MN)
• Table 4 Global Herbal Immunity Boosters Market Outlook, By Echinacea (2023-2034) ($MN)
• Table 5 Global Herbal Immunity Boosters Market Outlook, By Elderberry (2023-2034) ($MN)
• Table 6 Global Herbal Immunity Boosters Market Outlook, By Astragalus (2023-2034) ($MN)
• Table 7 Global Herbal Immunity Boosters Market Outlook, By Ginseng (2023-2034) ($MN)
• Table 8 Global Herbal Immunity Boosters Market Outlook, By Turmeric/Curcumin (2023-2034) ($MN)
• Table 9 Global Herbal Immunity Boosters Market Outlook, By Vitamins & Minerals (2023-2034) ($MN)
• Table 10 Global Herbal Immunity Boosters Market Outlook, By Vitamin C (2023-2034) ($MN)
• Table 11 Global Herbal Immunity Boosters Market Outlook, By Vitamin D (2023-2034) ($MN)
• Table 12 Global Herbal Immunity Boosters Market Outlook, By Zinc (2023-2034) ($MN)
• Table 13 Global Herbal Immunity Boosters Market Outlook, By Probiotics (2023-2034) ($MN)
• Table 14 Global Herbal Immunity Boosters Market Outlook, By Functional Foods & Beverages (2023-2034) ($MN)
• Table 15 Global Herbal Immunity Boosters Market Outlook, By Immunity-Boosting Drinks (2023-2034) ($MN)
• Table 16 Global Herbal Immunity Boosters Market Outlook, By Fortified Snacks (2023-2034) ($MN)
• Table 17 Global Herbal Immunity Boosters Market Outlook, By Functional Teas (2023-2034) ($MN)
• Table 18 Global Herbal Immunity Boosters Market Outlook, By Essential Oils (2023-2034) ($MN)
• Table 19 Global Herbal Immunity Boosters Market Outlook, By Form (2023-2034) ($MN)
• Table 20 Global Herbal Immunity Boosters Market Outlook, By Tablets (2023-2034) ($MN)
• Table 21 Global Herbal Immunity Boosters Market Outlook, By Capsules (2023-2034) ($MN)
• Table 22 Global Herbal Immunity Boosters Market Outlook, By Powder (2023-2034) ($MN)
• Table 23 Global Herbal Immunity Boosters Market Outlook, By Liquid (2023-2034) ($MN)
• Table 24 Global Herbal Immunity Boosters Market Outlook, By Gummies & Chewables (2023-2034) ($MN)
• Table 25 Global Herbal Immunity Boosters Market Outlook, By Other Forms (2023-2034) ($MN)
• Table 26 Global Herbal Immunity Boosters Market Outlook, By Source (2023-2034) ($MN)
• Table 27 Global Herbal Immunity Boosters Market Outlook, By Plant (2023-2034) ($MN)
• Table 28 Global Herbal Immunity Boosters Market Outlook, By Animal (2023-2034) ($MN)
• Table 29 Global Herbal Immunity Boosters Market Outlook, By Microbial (2023-2034) ($MN)
• Table 30 Global Herbal Immunity Boosters Market Outlook, By Application (2023-2034) ($MN)
• Table 31 Global Herbal Immunity Boosters Market Outlook, By Immune System Support (2023-2034) ($MN)
• Table 32 Global Herbal Immunity Boosters Market Outlook, By Cold & Flu Relief (2023-2034) ($MN)
• Table 33 Global Herbal Immunity Boosters Market Outlook, By Allergy Management (2023-2034) ($MN)
• Table 34 Global Herbal Immunity Boosters Market Outlook, By Respiratory Health (2023-2034) ($MN)
• Table 35 Global Herbal Immunity Boosters Market Outlook, By Digestive Health (2023-2034) ($MN)
• Table 36 Global Herbal Immunity Boosters Market Outlook, By End User (2023-2034) ($MN)
• Table 37 Global Herbal Immunity Boosters Market Outlook, By Adults (2023-2034) ($MN)
• Table 38 Global Herbal Immunity Boosters Market Outlook, By Children (2023-2034) ($MN)
• Table 39 Global Herbal Immunity Boosters Market Outlook, By Geriatric (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.